￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
028-123456789
Menu

Oncology

Data on the efficacy of entrectinib in the treatment of ROS1-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How much does a cycle of ramucirumab cost for lung cancer?

2025-10-19 11:44:20

Check Details
The difference between ramucirumab and bevacizumab_Canghule

2025-10-19 11:44:20

Check Details
Pictures and introduction of entrectinib targeted drug

2025-10-19 11:44:20

Check Details
Ramucirumab + docetaxel in the treatment of advanced non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Can ramucirumab be purchased in the country? How much does one cost?

2025-10-19 11:44:20

Check Details
New treatment method for EGFR mutated lung cancer: ramucirumab + erlotinib

2025-10-19 11:44:20

Check Details
Data on the efficacy of ramucirumab in the treatment of metastatic non-small cell lung cancer with EGFR gene mutations

2025-10-19 11:44:20

Check Details
Safety and effectiveness of the targeted drug entrectinib in the treatment of ROS1 lung cancer

2025-10-19 11:44:20

Check Details
Ramucirumab + docetaxel for metastatic non-small cell lung cancer that worsens during or after platinum-containing chemotherapy_ Kanghule

2025-10-19 11:44:20

Check Details
The first NTRK inhibitor approved by the FDA - larotrectinib (LOXO101)_ Kanghule

2025-10-19 11:44:20

Check Details
Efficacy data of larotrectinib in the treatment of NTRK mutation-positive lung cancer

2025-10-19 11:44:20

Check Details
Category
相关知识